- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02891889
Description of the Appearance of Brown Fat in Scanner (BAT)
September 7, 2016 updated by: University Hospital, Brest
The aim of this study is to investigate aspects of brown fat in scanner with injection via the PET-CT study.
Study Overview
Status
Completed
Conditions
Detailed Description
Brown fat is metabolically active adipose tissue.
It can be responsible in PET-CT of a fixation of 18-FDG and a look of pseudo-infiltration of fat.
These aspects can be sources of false positives.
The objective here is to gain a better knowledge of the scanner in areas of brown fat.
Study Type
Observational
Enrollment (Actual)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Brest, France, 29609
- CHRU de Brest
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients had a thoraco-abdominopelvic PET-CT examination with18F-FDG in a clinical setting which warranted.
Description
Inclusion Criteria:
- Consecutive patients since June 2014, who underwent a thoraco-abdominopelvic PET-CT examination with 18F-FDG in the University Hospital of Brest, in a clinical setting which warranted.
- Major Patients
- No opposition formalized
Exclusion Criteria:
- Refusal of participation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Density value
Time Frame: 1 year
|
measured by CT and expressed in Hounsfield Units
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Standard Uptake Values (SUV) adipose tissue "white" and "brown".
Time Frame: 1 year
|
SUV maximum and average
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Douraied Ben Salem, Professor, CHRU de Brest
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2015
Primary Completion (Actual)
November 1, 2015
Study Completion (Actual)
November 1, 2015
Study Registration Dates
First Submitted
August 30, 2016
First Submitted That Met QC Criteria
September 7, 2016
First Posted (Estimate)
September 8, 2016
Study Record Updates
Last Update Posted (Estimate)
September 8, 2016
Last Update Submitted That Met QC Criteria
September 7, 2016
Last Verified
September 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- BAT
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Description of Brown Fat
-
Tang-Du HospitalRecruitingBrown Fat and Muscle Metabolic | Differential DiagnosisChina
-
Otto MuzikUnknownBrown FatUnited States
-
Hospital General ValenciaRecruitingBrief Description of Focus of Study InsteadSpain
-
AstraZenecaActive, not recruitingDescription of SLE Activity in Patients in Routine Practice in the Republic of Kazakhstan | Description of the Course of SLE in Patients in the Republic of Kazakhstan | Description of Methods and Approaches to the Treatment of Patients With SLE in the Republic of KazakhstanKazakhstan
-
Susanna SøbergCompletedObesity | Type 2 Diabetes | Adipokines | Brown Adipose Tissue | Proteomics | Infrared Thermography | Adipose Tissue, Brown | Uncoupling Protein 1 | Brown Fat | BAT | ProteinsDenmark
-
Rigshospitalet, DenmarkCompletedType2 Diabetes | Adipose Tissue | Adipokines | Brown Adipose Tissue | Proteomics | Uncoupling Protein 1 | Brown Fat | Infra-red Thermography | BAT | Winter Swimmers | ProteinsDenmark
-
Worabe Comprehensive Specialiazed HospitalCompletedThe Focus of Study is Description of a Very Rare CaseEthiopia
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
Zhejiang Wenda Medical Technology Co., Ltd.RecruitingBrief Description of Focus of StudyChina
-
Sorlandet Hospital HFOslo University HospitalCompletedBrief Description of the Focus of the Study: Number of Injuries to Bicyclists and Micro Mobility UsersNorway